Clinical Trials Directory

Trials / Unknown

UnknownNCT05926557

Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel

Treatment of Peri-implant Mucositis by Non-surgical Debridement and Additional Application of a Spermidine-based Gel

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to evaluate the potential of a spermidine-based topical gel as an adjuvant to non-surgical treatment of peri-implant mucositis. After a meticulous selection, patients will be randomly assigned to Test (spermidine gel + non-surgical debridement) or Control group (non-surgical debridement).

Detailed description

Following the recording of the clinical parameters (BoP, FMPS, FMBS, PD), mechanical therapy (NSMD) will be performed in the Test group (spermidine gel) by means of an ultrasonic scaler with a plastic tip. Finally, the spermidine-based gel will be applied in the peri-implant sulcus using a blunt-tipped needle. Control group will instead be treated only through the NSMD. Finally, after 3 months the clinical parameters (BoP, FMPS, FMBS, PD) will be recorded again and the final evaluation will be performed. Data analysis will be performed using statistical software.

Conditions

Interventions

TypeNameDescription
PROCEDURESpermidine gelFirst step: Non-surgical mechanical debridement (NSMD) Second step: application of spermidine gel
PROCEDURENSMDOnly mechanical debridement with curettes and scaler peek tips

Timeline

Start date
2023-07-01
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2023-07-03
Last updated
2024-05-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05926557. Inclusion in this directory is not an endorsement.

Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel (NCT05926557) · Clinical Trials Directory